Andrew M. Haidle,Michael D. Altman,Solomon D. Kattar,Matthew Christopher,John Michael Ellis,Christian Fischer,Alan B. Northrup,Kaleen Konrad Childers
申请号：
US14409200
公开号：
US09416111B2
申请日:
2013.06.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides certain substituted diazine and triazine compounds of the Formula (I) (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, Cy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.
